SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-18-008392
Filing Date
2018-12-10
Accepted
2018-12-10 13:56:38
Documents
5
Period of Report
2018-12-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_121018.htm 6-K 13031
2 EXHIBIT 1.1 exh_11.htm EX-1.1 375488
3 EXHIBIT 5.1 exh_51.htm EX-5.1 8792
4 EXHIBIT 5.2 exh_52.htm EX-5.2 8849
5 GRAPHIC gkh_logo.jpg GRAPHIC 6964
  Complete submission text file 0001171843-18-008392.txt   416836
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 181225777
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1